PepGen Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PEPG research report →
Companywww.pepgen.com
PepGen Inc. , a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD).
- CEO
- James G. McArthur
- IPO
- 2022
- Employees
- 79
- HQ
- Boston, MA, US
Price Chart
Valuation
- Market Cap
- $99.60M
- P/E
- -1.29
- P/S
- 0.00
- P/B
- 0.74
- EV/EBITDA
- -0.92
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -59.89%
- ROIC
- -53.96%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-89,655,000 · 0.36%
- EPS
- $-2.12 · 25.61%
- Op Income
- $-93,612,000
- FCF YoY
- 1.17%
Performance & Tape
- 52W High
- $7.80
- 52W Low
- $1.01
- 50D MA
- $2.71
- 200D MA
- $4.03
- Beta
- 2.01
- Avg Volume
- 1.44M
Get TickerSpark's AI analysis on PEPG
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 4, 26 | STRECK PAUL | sell | 1,832 |
| Mar 4, 26 | STRECK PAUL | sell | 47 |
| Mar 4, 26 | Donnelly Noel | sell | 2,032 |
| Mar 4, 26 | Donnelly Noel | sell | 52 |
| Mar 4, 26 | McArthur James G | sell | 5,144 |
| Mar 4, 26 | McArthur James G | sell | 131 |
| Mar 1, 26 | Vittiglio Joseph | other | 120,000 |
| Mar 1, 26 | Vittiglio Joseph | other | 30,717 |
| Mar 1, 26 | Kasraian Kasra | other | 135,000 |
| Mar 1, 26 | Kasraian Kasra | other | 34,557 |
Our PEPG Coverage
We haven't published any research on PEPG yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PEPG Report →